What is the appropriate acute and preventive management for a 12‑year‑old with disabling migraine and photophobia that requires staying in a dark room all day?

Immediate Management for Disabling Pediatric Migraine

This 12-year-old requires both aggressive acute treatment with ibuprofen (7.5-10 mg/kg) at the first sign of headache and initiation of preventive therapy given the disabling nature of these attacks. 1

Acute Treatment Strategy

Start with ibuprofen as first-line acute therapy - it has the strongest evidence in this age group and should be given early in the attack, not after the child is already confined to a dark room 1, 2. The key is treating at the first sign of headache, before full disability sets in.

Acute Treatment Algorithm:

• First-line: Ibuprofen 7.5-10 mg/kg per dose 1
• If inadequate response: Consider adding or switching to a triptan formulation:
  • Nasal spray options (zolmitriptan or sumatriptan nasal) work faster than oral and are particularly useful when pain escalates quickly 1
  • Rizatriptan ODT or almotriptan oral are alternatives 1
• If nausea/vomiting present: Use non-oral triptan formulation or add an anti-emetic 1
• If one triptan fails: Try a different triptan or an NSAID-triptan combination 1

Critical Pitfall to Avoid:

Counsel the family about medication overuse headache - using acute medications more than 2-3 days per week can worsen the migraine pattern and create a vicious cycle 1.

Preventive Therapy - Essential for This Patient

Given that this child cannot function and must stay in a dark room all day, preventive therapy is clearly indicated 1. This level of disability mandates prevention, not just acute treatment.

Important Counseling Point:

Before starting preventive medication, you must discuss with the family that placebo was as effective as active medication in many pediatric migraine prevention trials 1. This doesn't mean prevention doesn't work - it means the decision should be shared and expectations realistic.

Preventive Medication Options (in order of evidence strength):

First-tier options with best evidence:

• Amitriptyline combined with cognitive behavioral therapy (CBT) - this combination has the strongest recommendation 1
• Topiramate - has evidence but requires counseling about teratogenic effects if the patient is female and approaching reproductive age; must use effective birth control and take folate 1
• Propranolol - has evidence for prevention 1

Key distinction: Amitriptyline alone has weaker evidence than amitriptyline with CBT 1. The behavioral component is not optional for optimal outcomes.

Non-Pharmacologic Interventions - Not Optional

These are foundational and must be implemented alongside medication:

• Lifestyle regulation: Regular sleep schedule, regular meals, adequate hydration 1
• Trigger identification and avoidance - though note that "light as a trigger" is often false attribution; photophobia is typically an early symptom of the attack, not the cause 3
• Cognitive behavioral therapy - this enhances medication efficacy, particularly with amitriptyline 1

Regarding the Dark Room Behavior:

While seeking darkness is a natural response to photophobia during an attack, the goal of treatment is to prevent attacks from reaching this severity. The photophobia and light sensitivity are manifestations of trigeminovascular system activation 3, not simply environmental sensitivity.

Treatment Sequence for This Specific Case:

1. Immediately: Optimize acute treatment - ensure ibuprofen is given at first headache symptom, not after disability occurs
2. Simultaneously: Initiate preventive therapy discussion - given the frequency and disability, this cannot wait
3. Within 1-2 weeks: Begin preventive medication (amitriptyline + CBT preferred) while establishing lifestyle modifications
4. Ongoing: Monitor for medication overuse, adjust preventive therapy after 6-8 week trial if inadequate response

If Preventive Medications Fail:

The evidence for second-line agents (divalproex, onabotulinumtoxinA, nimodipine) is weaker in pediatrics 1, but may be considered if first-line options fail and disability persists.

The combination of early acute treatment, appropriate preventive therapy, and behavioral interventions should restore this child's ability to function rather than spending entire days in a dark room.